In vitro antifungal activity of the berberine and its synergism with fluconazole

Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology

Volumn 97, Issue 2, 2010, Pages 201-205

  Iwazaki, Renata Sayuri ^a   Endo, Eliana Harue ^a   Ueda Nakamura, Tânia ^a   Nakamura, Celso Vataru ^a   Garcia, Lourdes Botelho ^a   Filho, Benedito Prado Dias ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Berberine; Candida albicans; Checkerboard; Fluconazole; Synergism

Indexed keywords

BERBERINE; FLUCONAZOLE; GLUCOSE; PEPTONE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DISK DIFFUSION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TURBIDITY; YEAST;

ANTIFUNGAL AGENTS; BERBERINE; CANDIDA ALBICANS; CANDIDIASIS; DRUG SYNERGISM; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS;

CANDIDA ALBICANS;

EID: 77649186191     PISSN: 00036072     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10482-009-9394-8     Document Type: Article

References (22)

1. TC Birdsall 1997 Berberine: therapeutic potential of an alkaloid found in several medicinal plants Altern Med Rev 2 2 94 103
2. Clinical and Laboratory Standards Institute (CLSI) (2004) Method for antifungal disk diffusion susceptibility testing of yeasts: NCCLS document M44-A. National Committee for Clinical Laboratory Standards, Wayne, Pa, pp 1-36
3. O Gudlaugsson S Gillespie K Lee J Vande Berg J Hu S Messer L Herwaldt M Pfaller D Diekema 2003 Attributable mortality of nosocomial candidemia, revisited Clin Infect Dis 37 1172 1177 10.1086/378745 14557960 (Pubitemid 37372504)
4. BR Jennings PJ Ridler 1983 Interaction of chromosomal stains with DNA, an electrofluorescence study Biophys Struct Mech 10 71 79 10.1007/BF00535543 1:CAS:528:DyaL3sXlsFequ7o%3D 6193819
5. W Ko X Yao C Lau W Law Z Chen W Kwok K Ho Y Huang 2000 Vasorelaxant and antiproliferative effects of berberine Eur J Pharmacol 399 187 196 10.1016/S0014-2999(00)00339-3 1:CAS:528:DC%2BD3cXksFGit7o%3D 10884519 (Pubitemid 30407040)
6. C Kuo C Chi T Liu 2004 The anti-inflammatory potential of berberine in vitro and in vivo Cancer Lett 203 127 137 10.1016/j.canlet.2003.09.002 1:CAS:528:DC%2BD2cXjsV2ksg%3D%3D 14732220 (Pubitemid 38063132)
7. K Lewis 2001 In search of natural substrates and inhibitors of MDR pumps J Mol Microbiol Biotechnol 2 3 247 254
8. M Lipsitch CT Bergstrom BR Levin 2000 The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions Proc Natl Acad Sci USA 97 1938 1943 10.1073/pnas.97.4.1938 1:CAS:528:DC%2BD3cXhsFCrurs%3D 10677558 (Pubitemid 30118547)
9. O Marchetti P Moreillon MP Glauser J Bille D Sanglard 2000 Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans Antimicrob Agents Chemother 44 2373 2381 10.1128/AAC.44.9.2373-2381.2000 1:CAS:528:DC%2BD3cXmtFylsbY%3D 10952582 (Pubitemid 30650882)
10. E Marinova D Nikolova D Popova G Gallacher N Ivanovska 2000 Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine Immunopharmacology 48 9 16 10.1016/S0162-3109(99)00189-7 1:CAS:528:DC%2BD3cXjsVGju78%3D 10822084 (Pubitemid 30259138)
11. N Mitani K Murakami T Yamaura T Ikeda I Saiki 2001 Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma Cancer Lett 165 35 42 10.1016/S0304- 3835(00)00710-2 1:CAS:528:DC%2BD3MXhvVahtb8%3D 11248416 (Pubitemid 32206655)
12. F Odds 2003 Synergy, antagonism, and what the checkerboard puts between them J Antim Chemother 52 1 10.1093/jac/dkg301 1:CAS:528:DC%2BD3sXltVWjsr0%3D
13. KS Park KC Kang JH Kim DJ Adams TN Johng YK Paik 1999 Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans J Antimicrob Chemother 43 667 674 10.1093/jac/43.5.667 1:CAS:528:DyaK1MXjsV2isL4%3D 10382888 (Pubitemid 29231692)
14. S Perea TF Patterson 2002 Antifungal resistance in pathogenic fungi Clin Infect Dis 35 1073 1080 10.1086/344058 12384841 (Pubitemid 35239467)
15. A Polak 1990 Combination therapy in systemic mycosis J Chemother 2 211 217 1:STN:280:DyaK3M%2FjvVaitg%3D%3D 2230904
16. II Severina MS Muntyan K Lewis VP Skulachev 2001 Transfer of cationic antibacterial agents beerberine, palmatine and benzalkonium through bimolecular planar phospholipid film and Staphylococcus aureus membrane IUBMB-Life Sci 52 321 324 10.1080/152165401317291183 1:CAS:528:DC%2BD38XitFCks78%3D
17. FR Stermitz P Lorenz JN Tawara LA Zenewicz K Lewis 2000 Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor Proc Natl Acad Sci 97 1433 1437 10.1073/pnas.030540597 1:CAS:528:DC%2BD3cXhsFCku7g%3D 10677479 (Pubitemid 30118458)
18. FR Stermitz J Tawara-Matsuda P Lorenz P Mueller L Zenewicz K Lewis 2000 5′-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus J Nat Prod 63 1146 1149 10.1021/np990639k 1:CAS:528:DC%2BD3cXkvFSit7c%3D 10978214 (Pubitemid 30678004)
19. FR Stermitz TD Beeson PJ Mueller JF Hsiang K Lewis 2001 Staphylococcus aureus MDR efflux pump inhibitors from a Berberis and a Mahonia (sensu strictu) species Biochem Syst Ecol 29 793 798 10.1016/S0305-1978(01)00025-4 1:CAS:528:DC%2BD3MXksVKis70%3D 11412952 (Pubitemid 32625130)
20. A Vollekova D Kost'alova V Kettmann J Toth 2003 Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids Phytother Res 17 834 837 10.1002/ptr.1256 1:CAS:528:DC%2BD3sXnsVSmsL8%3D 12916091 (Pubitemid 37012274)
21. TC White KA Marr RA Bowden 1998 Clinical, cellular, and molecular factors that contribute to antifungal drug resistance Clin Microbiol Rev 11 2 382 402 1:CAS:528:DyaK1cXislers7w%3D 9564569
22. XZ Zhao X Guo 1989 Antiarrhythmic effect and electrophysiologic study of berberine Zhong Hua Xin Xue Guan Bing Za Zhi 17 159 161 1:STN:280: DyaK3c%2FptFOltQ%3D%3D